🇺🇸 FDA
Patent

US 11613764

T cell receptors that bind to NY-ESO-1 and methods of use thereof

granted A61KA61K40/11A61K40/32

Quick answer

US patent 11613764 (T cell receptors that bind to NY-ESO-1 and methods of use thereof) held by MiNK Therapeutics, Inc. expires Mon Mar 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
MiNK Therapeutics, Inc.
Grant date
Tue Mar 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K40/11, A61K40/32, A61K40/4267, A61K40/4269